Making sense of the evidence regarding nonhormonal treatments for hot flashes

Debra Barton1, Charles L Loprinzi

  • 1barton.debra@mayo.edu

Insights

Nonhormonal treatments for hot flashes are increasingly important. This review summarizes evidence for antidepressants and gabapentin to help clinicians manage disruptive hot flashes.

Area of Science:

  • Women's Health
  • Clinical Therapeutics
  • Pharmacology

Background:

  • Growing demand for nonhormonal hot flash interventions due to cancer diagnoses and Women's Health Initiative findings.
  • Hormone replacement therapy (HRT) is now viewed as less beneficial and carries risks.
  • Hot flashes significantly impact daily life, including sleep and work.

Purpose of the Study:

  • To summarize evidence for nonhormonal hot flash treatments.
  • To provide clinicians with research findings for patient treatment decisions.
  • To offer a clinical decision algorithm for managing hot flashes.

Main Methods:

  • Systematic review of studies on nonhormonal hot flash interventions published since 2002.
  • Evaluation of evidence for specific nonhormonal options, including antidepressants and gabapentin.
  • Inclusion of a review of complementary therapies for hot flashes.

Main Results:

  • Evidence for nonhormonal interventions is summarized to guide clinical practice.
  • A treatment algorithm is proposed, incorporating antidepressants and gabapentin.
  • Complementary therapies are briefly reviewed for potential use.

Conclusions:

  • Clinicians should assess the disruptive impact of hot flashes on patients' lives.
  • Nonhormonal options like antidepressants and gabapentin are viable alternatives to HRT.
  • The provided algorithm can aid in selecting appropriate nonhormonal treatments for hot flashes.